Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene-Reference-Cited by-同舟云学术

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene

Published:2018-10 Issue: Volume:55 Page:45-49
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Thaler Avner^ORCID,Bregman Noa,Gurevich Tanya,Shiner Tamara,Dror Yonatan,Zmira Ofir,Gan-Or Ziv^ORCID,Bar-Shira Anat,Gana-Weisz Mali,Orr-Urtreger Avi,Giladi Nir^ORCID,Mirelman Anat

Funder

National Parkinson Foundation

Solvay pharmaceuticals

TEVA

RAFA

Medtronic

Novartis

Medison

Allergan

GlaxoSmithKline

Perrigo and Intecpharma

Israeli Science Foundation Legacy Heritage Fund

Department of Health, Israel

ALS Association USA

Kahn Foundation Israel

Teva-Lundbeck

UCB

NeuroDerm

NPF

Israeli Science Foundation

NIH

MJFF

EU FP7

Ministry of Science and Technology, Israel

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Gaucher disease: gene frequencies in the Ashkenazi Jewish population;Beutler;Am. J. Hum. Genet.,1993

2. The relationship between glucocerebrosidase mutations and Parkinson disease;Migdalska-Richards;J. Neurochem.,2016

3. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease;Sidransky;N. Engl. J. Med.,2009

4. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies;Nalls;JAMA Neurol,2013

5. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease;Neumann;Brain,2009

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations;Parkinsonism & Related Disorders;2024-10

2. A benign course of Parkinson's disease associated with different mutations in the glucocerebrosidase gene – A case series;Parkinsonism & Related Disorders;2024-07

3. Genetics of Parkinson's disease: Dominant forms and GBA;Neurology Perspectives;2024-07

4. Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2/GBA mutated Parkinson's disease;CNS Neuroscience & Therapeutics;2024-06

5. GBA1-and LRRK2-directed Treatments: The Way Forward;Parkinsonism & Related Disorders;2024-05